CHS (CHSCP)
(Delayed Data from NSDQ)
$30.07 USD
-0.13 (-0.44%)
Updated Apr 26, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for CHS Inc falls in the month of August .
All items in Millions except EPS data.
8/31/23 | 8/31/22 | 8/31/21 | 8/31/20 | 8/31/19 | |
---|---|---|---|---|---|
Sales | 45,590 | 47,792 | 38,448 | 28,406 | 31,900 |
Cost Of Goods | 43,214 | 45,665 | 37,497 | 27,425 | 30,516 |
Gross Profit | 2,376 | 2,127 | 951 | 982 | 1,384 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,033 | 998 | 746 | 705 | 725 |
Income After Depreciation & Amortization | 1,344 | 1,129 | 206 | 277 | 660 |
Non-Operating Income | 802 | 795 | 414 | 227 | 323 |
Interest Expense | 137 | 114 | 105 | 117 | 167 |
Pretax Income | 2,008 | 1,810 | 515 | 387 | 816 |
Income Taxes | 108 | 132 | -38 | -37 | -12 |
Minority Interest | 0 | -1 | 0 | 1 | -2 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1,900 | 1,678 | 554 | 424 | 828 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 1,900 | 1,679 | 554 | 422 | 830 |
Depreciation Footnote | 8/31/23 | 8/31/22 | 8/31/21 | 8/31/20 | 8/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,883 | 1,666 | 741 | 828 | 1,201 |
Depreciation & Amortization (Cash Flow) | 540 | 536 | 536 | 550 | 542 |
Income After Depreciation & Amortization | 1,344 | 1,129 | 206 | 277 | 660 |
Earnings Per Share Data | 8/31/23 | 8/31/22 | 8/31/21 | 8/31/20 | 8/31/19 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |
Fiscal Year end for CHS Inc falls in the month of August .
All items in Millions except EPS data.
2/29/24 | 11/30/23 | 8/31/23 | 5/31/23 | 2/28/23 | |
---|---|---|---|---|---|
Sales | 9,087.48 | 11,390.66 | 9,491.27 | 12,026.05 | 11,306.85 |
Cost Of Goods | 8,721.59 | 10,745.71 | 9,052.74 | 11,351.71 | 10,922.58 |
Gross Profit | 365.89 | 644.95 | 438.53 | 674.34 | 384.27 |
SG&A, R&D, and Dept/Amort Expenses | 298.23 | 252.06 | 282.94 | 273.24 | 241.93 |
Income After SG&A, R&D, and Dept/Amort Expenses | 67.66 | 392.89 | 155.59 | 401.10 | 142.34 |
Non-Operating Income | 143.46 | 153.58 | 194.86 | 193.97 | 206.65 |
Interest Expense | 25.46 | 29.63 | 31.28 | 36.95 | 35.97 |
Pretax Income | 185.66 | 516.85 | 319.17 | 558.12 | 313.02 |
Income Taxes | 15.33 | -6.52 | 41.35 | 10.78 | 20.97 |
Minority Interest | 0.03 | 0.45 | -0.20 | -0.16 | -0.27 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 170.33 | 523.37 | 277.82 | 547.34 | 292.05 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 170.31 | 522.92 | 278.02 | 547.50 | 292.32 |
Earnings Per Share Data | 2/29/24 | 11/30/23 | 8/31/23 | 5/31/23 | 2/28/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |